Exudative versus Nonexudative Age-Related Macular Degeneration: Physiopathology and Treatment Options.

age-related macular degeneration antiangiogenic agents choroidal neovascularization geographic atrophy inflammatory cascade

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
26 Feb 2022
Historique:
received: 10 02 2022
revised: 24 02 2022
accepted: 25 02 2022
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 9 4 2022
Statut: epublish

Résumé

Age-related macular degeneration (AMD) is an eye disease typically associated with the aging and can be classified into two types-namely, the exudative and the nonexudative AMD. Currently available treatments for exudative AMD use intravitreal injections, which are associated with high risk of infection that can lead to endophthalmitis, while no successful treatments yet exist for the nonexudative form of AMD. In addition to the pharmacologic therapies administered by intravitreal injection already approved by the Food and Drug Administration (FDA) in exudative AMD, there are some laser treatments approved that can be used in combination with the pharmacological therapies. In this review, we discuss the latest developments of treatment options for AMD. Relevant literature available from 1993 was used, which included original articles and reviews available in PubMed database and also information collected from Clinical Trials Gov website using "age-related macular degeneration" and "antiangiogenic therapies" as keywords. The clinical trials search was limited to ongoing trials from 2015 to date.

Identifiants

pubmed: 35269743
pii: ijms23052592
doi: 10.3390/ijms23052592
pmc: PMC8910030
pii:
doi:

Substances chimiques

Angiogenesis Inhibitors 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Portuguese Science and Technology Foundation (FCT) from the Ministry of Science and Technology (MCTES), European Social Fund (FSE)
ID : SFRH/BD/130555/2017, UIDB/04469/2020 (CEB strategic fund), UIDB/04033/2020 (CITAB)
Organisme : National Science Centre
ID : MINIATURA 4 (grant no: 2020/04/X/ST5/00789)
Organisme : Foundation for Polish Science
ID : START 2021 Program

Références

EMBO Mol Med. 2019 May;11(5):
pubmed: 31040129
N Engl J Med. 2006 Oct 5;355(14):1419-31
pubmed: 17021318
Retina. 2010 Jan;30(1):6-15
pubmed: 20066766
Nat Rev Dis Primers. 2021 May 6;7(1):31
pubmed: 33958600
Drug Des Devel Ther. 2016 Jun 02;10:1857-67
pubmed: 27330279
Am J Ophthalmol. 2017 May;177:150-158
pubmed: 28245970
Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4473-80
pubmed: 14507895
Arch Ophthalmol. 2002 Oct;120(10):1307-14
pubmed: 12365909
Proc Natl Acad Sci U S A. 2005 May 17;102(20):7227-32
pubmed: 15870199
J Stem Cells. 2015;10(3):171-91
pubmed: 27125062
Science. 2005 Apr 15;308(5720):385-9
pubmed: 15761122
Arch Ophthalmol. 2006 Jul;124(7):995-1001
pubmed: 16832023
Alzheimers Dement. 2019 Jan;15(1):34-41
pubmed: 30098888
Eye (Lond). 2020 Jun;34(6):1006-1007
pubmed: 31784703
Front Pharmacol. 2019 Nov 29;10:1363
pubmed: 31849644
Can J Ophthalmol. 2018 Apr;53(2):168-172
pubmed: 29631830
Ophthalmology. 2016 Jun;123(6):1278-86
pubmed: 26949121
J Ophthalmic Vis Res. 2019 Jan-Mar;14(1):78-87
pubmed: 30820291
Arch Ophthalmol. 2006 Apr;124(4):537-43
pubmed: 16606880
Semin Immunol. 2019 Oct;45:101341
pubmed: 31757608
Prog Retin Eye Res. 2005 Jan;24(1):87-138
pubmed: 15555528
Optom Vis Sci. 2014 Aug;91(8):950-5
pubmed: 24987815
Arch Ophthalmol. 2011 Jul;129(7):921-9
pubmed: 21402976
J Ophthalmol. 2013;2013:385915
pubmed: 23762528
Ophthalmology. 2004 Nov;111(11):1967-80
pubmed: 15522362
Ophthalmology. 2012 Jul;119(7):1388-98
pubmed: 22555112
Expert Opin Pharmacother. 2019 Oct;20(15):1879-1891
pubmed: 31298960
Ophthalmology. 2015 Jan;122(1):162-9
pubmed: 25200399
Arch Ophthalmol. 1993 Sep;111(9):1189-99
pubmed: 7689826
Am J Ophthalmol. 2004 Apr;137(4):770-3
pubmed: 15059729
Invest Ophthalmol Vis Sci. 2020 Nov 2;61(13):19
pubmed: 33186466
Invest Ophthalmol Vis Sci. 2011 Jun 01;52(6):3761-6
pubmed: 21310912
Exp Ther Med. 2020 Jun;19(6):3691-3697
pubmed: 32346433
Ophthalmology. 2010 Mar;117(3):500-11
pubmed: 20022638
Clin Interv Aging. 2017 Aug 22;12:1313-1330
pubmed: 28860733
Jpn J Ophthalmol. 2021 Nov;65(6):741-760
pubmed: 34491474
J Curr Ophthalmol. 2019 Oct 22;31(4):411-415
pubmed: 31844792
Br J Ophthalmol. 2006 Aug;90(8):1028-33
pubmed: 16723359
Artif Cells Nanomed Biotechnol. 2018 Dec;46(8):1694-1707
pubmed: 29065723
EMBO Mol Med. 2019 May;11(5):
pubmed: 31040126
Ophthalmic Surg Lasers Imaging Retina. 2017 Feb 1;48(2):100-104
pubmed: 28195611
Angiogenesis. 2012 Jun;15(2):171-85
pubmed: 22302382
Ophthalmology. 2005 Jun;112(6):1035-47
pubmed: 15936441
Ophthalmology. 2017 Dec;124(12):1753-1763
pubmed: 28712657
Arch Ophthalmol. 2005 Nov;123(11):1484-98
pubmed: 16286610
Int Ophthalmol Clin. 2015 Summer;55(3):63-78
pubmed: 26035762
Immunol Lett. 2009 Sep 22;126(1-2):1-7
pubmed: 19616581
Sci Transl Med. 2017 Jun 21;9(395):
pubmed: 28637922
J Clin Med. 2021 Jul 26;10(15):
pubmed: 34362080
Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5487-94
pubmed: 17122140
Acta Ophthalmol. 2012 Aug;90(5):e381-8
pubmed: 22490043
Ophthalmologica. 2011;226(4):182-90
pubmed: 21865677
J Leukoc Biol. 2015 Nov;98(5):713-25
pubmed: 26292978
Asia Pac J Ophthalmol (Phila). 2017 Nov-Dec;6(6):498-507
pubmed: 28905541
Nat Genet. 2013 Nov;45(11):1371-4
pubmed: 24036950
Cell. 2012 May 11;149(4):847-59
pubmed: 22541070
Semin Ophthalmol. 2011 May;26(3):225-33
pubmed: 21609236
Ophthalmology. 2001 Oct;108(10):1893-900; discussion 1900-1
pubmed: 11581068
Ophthalmology. 2004 May;111(5):857-62
pubmed: 15121359
Ophthalmology. 2009 Dec;116(12):2393-9
pubmed: 19815292
Nature. 2008 Jul 24;454(7203):428-35
pubmed: 18650913
Lancet. 2018 Sep 29;392(10153):1147-1159
pubmed: 30303083
Int J Retina Vitreous. 2017 May 1;3:6
pubmed: 28469938
Clin Interv Aging. 2017 Oct 03;12:1579-1587
pubmed: 29042759
Ophthalmic Physiol Opt. 2003 Sep;23(5):383-99
pubmed: 12950886
Surv Ophthalmol. 1999 Jul-Aug;44(1):1-29
pubmed: 10466585
Ophthalmologica. 2011;225(3):144-9
pubmed: 21071996
Invest Ophthalmol Vis Sci. 2010 Apr;51(4):2149-57
pubmed: 19797228
Ophthalmology. 2020 May;127(5):616-636
pubmed: 31864668
JAMA Ophthalmol. 2018 Jun 1;136(6):666-677
pubmed: 29801123
Lancet. 2015 Dec 12;386(10011):2395-403
pubmed: 26431823
Am J Pathol. 2005 Nov;167(5):1451-9
pubmed: 16251428
Cytokine Growth Factor Rev. 2004 Aug;15(4):197-204
pubmed: 15207811
Surv Ophthalmol. 2018 Mar - Apr;63(2):236-244
pubmed: 28648383
Arch Ophthalmol. 2004 Apr;122(4):564-72
pubmed: 15078675
Lancet. 2012 May 5;379(9827):1728-38
pubmed: 22559899
N Engl J Med. 2021 Aug 5;385(6):539-547
pubmed: 34347954
Dtsch Arztebl Int. 2020 Jul 20;117(29-30):513-520
pubmed: 33087239
Ophthalmology. 2012 Dec;119(12):2537-48
pubmed: 23084240
Arch Ophthalmol. 2011 Dec;129(12):1543-50
pubmed: 21825180
Optom Vis Sci. 2017 Feb;94(2):246-259
pubmed: 27668639
Arch Ophthalmol. 2001 Oct;119(10):1417-36
pubmed: 11594942
Int J Retina Vitreous. 2021 Oct 1;7(1):55
pubmed: 34598731
Prog Retin Eye Res. 2021 Sep;84:100952
pubmed: 33610747
Lancet. 2017 Jul 1;390(10089):50-61
pubmed: 28526489
Trials. 2015 Sep 21;16:419
pubmed: 26390920
Br J Ophthalmol. 2021 May;105(5):716-722
pubmed: 32586932
Am J Ophthalmol. 2011 May;151(5):745-751.e1
pubmed: 21501704
Br J Ophthalmol. 2010 Feb;94(2):180-4
pubmed: 19965822
Sci Rep. 2018 Jul 5;8(1):10207
pubmed: 29976989
Expert Opin Investig Drugs. 2009 Oct;18(10):1573-80
pubmed: 19694600
Hum Mol Genet. 2008 Jun 15;17(12):1821-4
pubmed: 18325906
Ophthalmology. 2013 Sep;120(9):1893-900
pubmed: 23490327
Ophthalmology. 2020 Jan;127(1):72-84
pubmed: 30986442
Ophthalmology. 2014 Mar;121(3):693-701
pubmed: 24289920
Retina. 2013 Mar;33(3):490-7
pubmed: 23403515
Ophthalmology. 2016 Oct;123(10):2225-31
pubmed: 27523614
Am J Ophthalmol. 1993 Jun 15;115(6):786-91
pubmed: 7685148
Am J Ophthalmol. 2014 Feb;157(2):464-469.e1
pubmed: 24315292
Cell Rep. 2013 Sep 12;4(5):945-58
pubmed: 24012762
Ophthalmic Epidemiol. 2020 Oct;27(5):399-408
pubmed: 32511069
Cochrane Database Syst Rev. 2017 Jul 30;7:CD000253
pubmed: 28756617
Arch Ophthalmol. 1995 Feb;113(2):185-9
pubmed: 7532394
Nutrition. 2018 Jul - Aug;51-52:6-12
pubmed: 29547735
Exp Eye Res. 2001 Dec;73(6):887-96
pubmed: 11846519
Hum Gene Ther. 2017 Jan;28(1):99-111
pubmed: 27710144
Ann Med. 2012 Feb;44(1):1-17
pubmed: 21284527
Curr Med Sci. 2020 Oct;40(5):851-857
pubmed: 32980899
Eye (Lond). 2017 Dec;31(12):1697-1706
pubmed: 28731052
Retina. 2016 Aug;36(8):1566-72
pubmed: 26807629
Biomed Res Int. 2018 Aug 26;2018:7532507
pubmed: 30225264
Acta Ophthalmol. 2012 Feb;90(1):61-7
pubmed: 20337606
Nat Genet. 2006 Apr;38(4):458-62
pubmed: 16518403
Clin Exp Optom. 2018 Mar;101(2):243-254
pubmed: 28994139
Cold Spring Harb Perspect Med. 2014 Oct 03;5(1):a017178
pubmed: 25280900
Neuro Oncol. 2005 Oct;7(4):452-64
pubmed: 16212810
Lancet Glob Health. 2014 Feb;2(2):e106-16
pubmed: 25104651
Br J Ophthalmol. 2013 Oct;97(10):1256-61
pubmed: 23843264
Clin Ophthalmol. 2018 Oct 24;12:2137-2143
pubmed: 30498330
Angiogenesis. 2007;10(2):141-8
pubmed: 17372853
Invest Ophthalmol Vis Sci. 2010 Aug;51(8):3846-52
pubmed: 20357194
Ophthalmology. 2012 Nov;119(11):2282-9
pubmed: 22840421
Arch Ophthalmol. 2000 Jan;118(1):78-84
pubmed: 10636419
Arch Ophthalmol. 2009 Dec;127(12):1596-602
pubmed: 20008714
EBioMedicine. 2016 Dec;14:168-175
pubmed: 27865764
Surv Ophthalmol. 2000 Jan-Feb;44(4):343-53
pubmed: 10667441
N Engl J Med. 2011 May 19;364(20):1897-908
pubmed: 21526923
Ophthalmology. 2015 Nov;122(11):2327-2335.e2
pubmed: 26337003
Trans Am Ophthalmol Soc. 2015;113:T8
pubmed: 26755855
BioDrugs. 2006;20(3):167-79
pubmed: 16724865
Med Clin North Am. 2021 May;105(3):473-491
pubmed: 33926642
Ophthalmic Surg Lasers Imaging Retina. 2014 Mar-Apr;45(2):143-9
pubmed: 24635156
Clin Ophthalmol. 2008 Jun;2(2):413-24
pubmed: 19668732
Nature. 2011 Mar 17;471(7338):325-30
pubmed: 21297615
Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6513-6528
pubmed: 29288272
Sci Rep. 2017 Mar 27;7:45081
pubmed: 28345626
Expert Opin Emerg Drugs. 2017 Sep;22(3):235-246
pubmed: 28756707
Ophthalmology. 2012 May;119(5):992-1000
pubmed: 22424834
Br J Ophthalmol. 2002 Jun;86(6):663-9
pubmed: 12034690
Am J Pathol. 2006 Jun;168(6):2036-53
pubmed: 16723717
Retina. 2012 Nov-Dec;32(10):2150-7
pubmed: 22617833
Clin Exp Ophthalmol. 2006 Jan-Feb;34(1):33-8
pubmed: 16451256
Adv Nutr. 2017 Jan 17;8(1):40-53
pubmed: 28096126
Surv Ophthalmol. 1995 Mar-Apr;39(5):367-74
pubmed: 7604360
N Engl J Med. 2004 Dec 30;351(27):2805-16
pubmed: 15625332
Int Arch Occup Environ Health. 2019 Jan;92(1):1-11
pubmed: 30191305
Immunogenetics. 2004 May;56(2):77-82
pubmed: 15118848
BMC Public Health. 2020 Mar 30;20(1):410
pubmed: 32228540
J Vis Impair Blind. 2008 Oct 1;102(10):600-610
pubmed: 20224750
Insight. 2004 Jan-Mar;29(1):15-6; quiz 17-8
pubmed: 15077399
Eur J Ophthalmol. 2021 Mar;31(2):514-520
pubmed: 32228026
Graefes Arch Clin Exp Ophthalmol. 2014 Sep;252(9):1403-11
pubmed: 24566902
Int J Retina Vitreous. 2017 Aug 21;3:31
pubmed: 28835854
Curr Opin Ophthalmol. 2004 Jun;15(3):181-3
pubmed: 15118503
JAMA Ophthalmol. 2017 Jul 1;135(7):761-767
pubmed: 28570723
Am J Ophthalmol. 2015 Dec;160(6):1226-34
pubmed: 26310670
Eur J Pharmacol. 2016 Sep 15;787:94-104
pubmed: 26948311
Sci Rep. 2018 Jun 6;8(1):8675
pubmed: 29875478
Photochem Photobiol. 1994 Mar;59(3):328-35
pubmed: 8016212
Nat Genet. 2013 Nov;45(11):1375-9
pubmed: 24036949
Ophthalmology. 2017 Feb;124(2):224-234
pubmed: 28029445
Ther Adv Chronic Dis. 2020 Sep 4;11:2040622320953349
pubmed: 32953000
Retina. 2007 Feb;27(2):133-40
pubmed: 17290193
Br J Ophthalmol. 2020 Jan;104(1):2-7
pubmed: 31315829
Nat Genet. 2006 Sep;38(9):1055-9
pubmed: 16936732
Am J Ophthalmol. 2013 Dec;156(6):1176-83
pubmed: 24083687
Gene Ther. 2009 Jan;16(1):10-6
pubmed: 18633446
Invest Ophthalmol Vis Sci. 2006 Feb;47(2):536-40
pubmed: 16431947
Int Ophthalmol. 2019 Dec;39(12):2975-2983
pubmed: 31313070

Auteurs

Ana Rita Fernandes (AR)

i3s-Institute for Research and Innovation in Health, University of Porto, R. Alfredo Allen 208, 4200-135 Porto, Portugal.
INEB-Biomedical Engineering Institute, University of Porto, Alfredo Allen 208, 4200-135 Porto, Portugal.
FEUP-Faculty of Engineering, University of Porto, R. Dr. Roberto Frias, 4200-465 Porto, Portugal.
Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy, University of Barcelona, 08001 Barcelona, Spain.
Centre for Research and Technology of Agro-Environmental and Biological Sciences, CITAB, UTAD, Quinta de Prados, 5001-801 Vila Real, Portugal.

Aleksandra Zielińska (A)

Institute of Human Genetics, Polish Academy of Sciences, Strzeszyńska 32, 60-479 Poznań, Poland.

Elena Sanchez-Lopez (E)

Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy, University of Barcelona, 08001 Barcelona, Spain.
Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, 08001 Barcelona, Spain.

Tiago Dos Santos (T)

i3s-Institute for Research and Innovation in Health, University of Porto, R. Alfredo Allen 208, 4200-135 Porto, Portugal.
INEB-Biomedical Engineering Institute, University of Porto, Alfredo Allen 208, 4200-135 Porto, Portugal.

Maria Luisa Garcia (ML)

Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy, University of Barcelona, 08001 Barcelona, Spain.
Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, 08001 Barcelona, Spain.

Amelia M Silva (AM)

Centre for Research and Technology of Agro-Environmental and Biological Sciences, CITAB, UTAD, Quinta de Prados, 5001-801 Vila Real, Portugal.
Department of Biology and Environment, University of Trás-os-Montes e Alto Douro, UTAD, Quinta de Prados, 5001-801 Vila Real, Portugal.

Jacek Karczewski (J)

Department of Environmental Medicine, Poznan University of Medical Sciences, 60-479 Poznań, Poland.
Department of Gastroenterology, Dietetics and Internal Diseases, H. Swiecicki University Hospital, Poznan University of Medical Sciences, 60-355 Poznań, Poland.

Eliana B Souto (EB)

Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.
CEB-Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
LABBELS-Associate Laboratory, 4800-122 Braga, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH